Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Its human clinical trial history two separate trials with no reported toxicity further differentiates it from peptides studied only in animal models
FOXO4-DRI is strictly intended for research purposes only and is not approved by the FDA for human use
On January 15, 2026 , Kyowa Hakko Bio Co., Ltd
Editorial Advisory Board Member, Harvard Health Publishing Teresa Fung, ScD, RD Contributor
US$ 21.03
US$ 23.17
US$ 21.45
US$ 21.70
US$ 29.70
US$ 29.44
US$ 22.22
US$ 25.46
US$ 24.05
US$ 20.73
US$ 25.95
US$ 21.87
US$ 20.88
